Founded in 2000, ClearLight targets investments in middle market companies. Based in Newport Beach, Calif., the firm prefers to make more substantial investments in companies from a number of sectors, including healthcare. Companies in its healthcare portfolio include The Outsource Group, a provider of first-party and third-party receivables management services. Read more about ClearLight at www.clearlightpartners.com
Founded in 2014, ClearPoint focuses exclusively on investments in lower middle market companies. Based in San Mateo, Calif., the firm targets business services and financial processing companies with revenue between $20 million and $200 million. Read more about ClearPoint at www.clearpointinvest.com
Founded in 1999, Clearview pursues majority ownership in lower middle market companies in healthcare and other industries. Within healthcare, the firm targets the provider services and non-reimbursement healthcare industries and pursues companies with revenues of at least $10 million. Clearview prefers to make more substantial investments from a dollars perspective. Companies in its healthcare portfolio include Apothecare, an institutional pharmacy targeting the behavioral health sector in group homes and community-based settings in Massachusetts; Community Medical Services, a provider of medication-assisted treatment programs for patients suffering from opioid use disorder; Pediatric Health Choice, a provider of alternative-site healthcare services for mentally complex, technology-dependent and behaviorally challenged children; and Pyramid Healthcare, a provider of behavioral health services, including substance use disorder and mental health treatment. Read more about Clearview at www.clearviewcap.com
CVC specializes in investments in lower middle market companies. The firm seeks control equity investment opportunities in companies with at least $15 million of sales and $2.5 million of cash flow. CVS is also willing to evaluate smaller strategic add-on acquisitions for its portfolio companies, and will consider partnering with other investors for larger transactions. Read more about CVC at www.commonviewcapital.com
Founded in 2005, CCP pursues investments in lower middle market companies exclusively in the healthcare industry. Based in New York, the firm targets companies that generally have between $20 million and $150 million in revenue. Companies in its portfolio include Bako Integrated Physician Solutions, a national provider of specialty laboratory testing services and other solutions, and Enclara Pharmacia, a national provider of hospice pharmacy services. Read more about CCP at www.consonancecapital.com/private-capital-for-the-middle-market/
Founded in 1985, Cortec seeks control equity in middle market companies. Based in New York, the firm invests in healthcare and several other sectors. Within healthcare, the firm targets the provider services and non-reimbursement healthcare industries. Cortec prefers to make more substantial investments from a dollars perspective. Companies in its healthcare portfolio include Aspen Medical Products, a designer, developer, manufacturer and marketer of upper and lower spinal orthopedic bracing products; Center for Vein Restoration, a manager of medical clinics providing treatment for varicose and spider veins; and Community Veterinary Partners, a network of veterinary hospitals located predominantly in the Northeastern United States. Read more about Cortec at www.cortecgroup.com
Founded in 2000, Council focuses exclusively on healthcare services and healthcare technology. Based in Nashville, Tenn., the firm targets growth and early-growth stage companies with revenues generally between $5 million and $50 million. Companies in its portfolio include Advanced Care Partners, a pediatric private duty nursing company; emids, a provider of information technology and business process outsourcing services; Caregiver, a provider of care to the IDD population; and SaVida Health, a network of outpatient treatment centers for opioid and alcohol dependency. Read more about Council at www.councilcapital.com
Established in June 2008, Cressey seeks control and minority equity investments exclusively in healthcare. With offices in Chicago and Nashville, the firm considers a wide range of investments in middle market companies. Companies in its portfolio includes Concentra, a provider of occupational medicine, urgent care, physical therapy and wellness services; Haven Behavioral Healthcare, a provider of specialty behavioral healthcare services; RestorixHealth, a developer and manager of centers of excellence for amputation prevention, wound management and hyperbaric medicine; and Unitek Information Systems, a provider of post-secondary healthcare education and short-term EMT and IT training. Read more about Cressey at www.cresseyco.com
Founded in 1997, Crestline pursues a wide range of investments in healthcare and other industries. Based in Fort Worth, Texas, the firm has wide flexibility on investment size in lower middle and middle market companies. Within healthcare, Crestline targets the provider services, hospitals/major facilities, life sciences/pharmaceutical and non-reimbursement industries. Companies in its healthcare portfolio include Urgent Team Holdings, an urgent care provider in the Southeastern United States; CarePayment Technologies, a self-pay revenue cycle management provider; Schweiger Dermatology, a provider of medical, cosmetic and surgical dermatology services; and SUN Behavioral Health, an inpatient behavioral hospital operator. Read more about Crestline at www.crestlineinvestors.com
Founded in 1983, DFW focuses on making control investments in lower middle market companies with revenue of $20 million to $100 million and EBITDA of $3 million to $10 million. Based in Teaneck, N.J., the firm invests in healthcare and a few other sectors. Companies in its portfolio include Children’s Dental Health Associates, a dental service organization providing management and support to pediatric dentists; Evolution Research Group, a provider of clinical research site services for special patient populations; and Saol Therapeutics, a specialty pharmaceutical company focused on rare diseases. Read more about DFW at www.dfwcapital.com